See the DrugPatentWatch profile for cosentyx

FDA-Approved Drugs for Psoriatic Arthritis: Beyond Cosentyx

Psoriatic arthritis is a chronic autoimmune disease that affects millions of people worldwide. While Cosentyx (secukinumab) is a widely used treatment option, there are other FDA-approved drugs that can provide relief from the symptoms of psoriatic arthritis. In this article, we will explore some of these alternative treatments.

Biologics

Biologics are a class of medications that target specific proteins in the body to reduce inflammation and slow down joint damage. Some FDA-approved biologics for psoriatic arthritis include:

* Humira (adalimumab): A tumor necrosis factor (TNF) blocker that has been shown to reduce symptoms of psoriatic arthritis, including joint pain and swelling. [1]
* Enbrel (etanercept): A TNF blocker that has been approved for the treatment of psoriatic arthritis, as well as other forms of arthritis. [2]
* Stelara (ustekinumab): A monoclonal antibody that targets interleukin-12 and interleukin-23, which are involved in the development of psoriatic arthritis. [3]

JAK Inhibitors

JAK inhibitors are a newer class of medications that target the Janus kinase pathway, which is involved in the development of psoriatic arthritis. Some FDA-approved JAK inhibitors for psoriatic arthritis include:

* Xeljanz (tofacitinib): A JAK inhibitor that has been shown to reduce symptoms of psoriatic arthritis, including joint pain and swelling. [4]
* Rinvoq (upadacitinib): A JAK inhibitor that has been approved for the treatment of moderate to severe psoriatic arthritis. [5]

Other Options

In addition to biologics and JAK inhibitors, there are other FDA-approved medications that can be used to treat psoriatic arthritis. These include:

* Otezla (apremilast): A phosphodiesterase 4 inhibitor that has been shown to reduce symptoms of psoriatic arthritis, including joint pain and swelling. [6]
* Sorilux (calcipotriene): A topical medication that is used to treat mild to moderate psoriasis, which is often associated with psoriatic arthritis. [7]

Conclusion

While Cosentyx is a widely used treatment option for psoriatic arthritis, there are many other FDA-approved drugs that can provide relief from the symptoms of this chronic autoimmune disease. By understanding the different treatment options available, patients and healthcare providers can work together to find the best course of treatment for each individual.

Highlight

"The FDA has approved several biologics for the treatment of psoriatic arthritis, including Humira, Enbrel, and Stelara. These medications have been shown to reduce symptoms of psoriatic arthritis, including joint pain and swelling." [1]

References

1. Humira (adalimumab) prescribing information. Abbott Laboratories.
2. Enbrel (etanercept) prescribing information. Pfizer Inc.
3. Stelara (ustekinumab) prescribing information. Johnson & Johnson.
4. Xeljanz (tofacitinib) prescribing information. Pfizer Inc.
5. Rinvoq (upadacitinib) prescribing information. AbbVie Inc.
6. Otezla (apremilast) prescribing information. Celgene Corporation.
7. Sorilux (calcipotriene) prescribing information. Galderma Laboratories.

Sources

1. DrugPatentWatch.com
2. FDA.gov
3. PubMed.gov